Filing Details
- Accession Number:
- 0001816590-23-000147
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-15 18:02:08
- Reporting Period:
- 2023-12-13
- Accepted Time:
- 2023-12-15 18:02:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1816590 | Compass Pathways Plc | CMPS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1898326 | Ekaterina Malievskaia | Compass Pathways Plc 33 Broadwick Street London X0 W1F 0DQ | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2023-12-13 | 2,855 | $7.82 | 4,264,586 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2023-12-13 | 2,855 | $7.82 | 4,267,244 | No | 4 | S | Indirect | By: Spouse |
Ordinary Shares | Disposition | 2023-12-14 | 1,377 | $7.81 | 4,263,209 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2023-12-14 | 1,377 | $7.81 | 4,265,867 | No | 4 | S | Indirect | By: Spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Indirect | By: Spouse |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By: Spouse |
Footnotes
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Dr. Malievskaia on August 23, 2023.
- The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Goldsmith on August 23, 2023.
- Securities held by George Jay Goldsmith, the Reporting Person's spouse. Dr. Malievskaia and Mr. Goldsmith are married but they expressly disclaim beneficial ownership of each other's shares in the Issuer.